Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Azacitidina con o sin lenalidomida o vorinostat en el tratamiento de pacientes con síndromes mielodisplásicos de alto riesgo o leucemia mielomonocítica crónica

10 de noviembre de 2026 actualizado por: National Cancer Institute (NCI)

Un estudio aleatorizado de fase II/III de azacitidina en combinación con lenalidomida (NSC-703813) frente a azacitidina sola frente a azacitidina en combinación con vorinostat (NSC-701852) para síndromes mielodisplásicos (SMD) de mayor riesgo y leucemia mielomonocítica crónica (CMML)

This randomized phase II/III trial studies how well azacitidine works with or without lenalidomide or vorinostat in treating patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, stopping them from dividing, or by stopping them from spreading. Lenalidomide may stop the growth of cancer cells by stopping blood flow to the cancer. Vorinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is not yet known whether azacitidine is more effective with or without lenalidomide or vorinostat in treating myelodysplastic syndromes or chronic myelomonocytic leukemia.

Descripción general del estudio

Descripción detallada

PRIMARY OBJECTIVES:

I. To select based on response rate (complete remission, partial remission, or hematologic improvement) either the combination of lenalidomide and azacitidine or the combination of vorinostat and azacitidine for further testing against single-agent azacitidine among patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). (Phase II) II. To compare overall survival between the combination arm selected in the Phase II portion of the trial to single-agent azacitidine among patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). (Phase III)

SECONDARY OBJECTIVES:

I. To estimate relapse-free survival, overall survival and cytogenetic response rate of patients treated on each regimen.

II. To estimate the frequency and severity of toxicities of the three regimens in this patient population.

III. To investigate in a preliminary manner the frequency of subgroups from prestudy cytogenetic studies and correlate these subgroups with clinical outcomes in this patient population.

IV. To collect specimens for banking for use in future research studies.

TERTIARY OBJECTIVES:

I. To evaluate the prevalence of a pre-specified list of molecular lesions (48 total lesions).

II. To assess associations of these lesions with outcomes (response, event-free survival, relapse-free survival, and overall survival).

III. To develop a deoxyribonucleic acid (DNA) methylation biomarker predictive of response to DMTi treatment in MDS.

IV. To harness gene expression profiles as clinical biomarkers of primary resistance to DMTi in MDS.

OUTLINE: Patients are randomized to 1 of 3 treatment arms. In Phase III, patients are randomized to 1 of 2 treatment arms (the combination arm selected in Phase II or the single-agent azacitidine arm).

ARM I: Patients receive azacitidine subcutaneously (SC) or intravenously (IV) on days 1-7 or days 1-5 and 8-9, and lenalidomide orally (PO) once daily (QD) on days 1-21.

ARM II: Patients receive azacitidine as in Arm I.

ARM III: Patients receive azacitidine as in Arm I and vorinostat PO twice daily (BID) on days 3-9.

In all arms, treatment repeats every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 3 months for up to 5 years.

Tipo de estudio

Intervencionista

Inscripción (Actual)

282

Fase

  • Fase 2

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Alberta
      • Calgary, Alberta, Canadá, T2N 5G2
        • Arthur J E Child Comprehensive Cancer Centre
    • British Columbia
      • Vancouver, British Columbia, Canadá, V5Z 3P1
        • Clinical Research Unit at Vancouver Coastal Health Authority
    • Manitoba
      • Winnipeg, Manitoba, Canadá, R3E 0V9
        • CancerCare Manitoba
    • New Brunswick
      • Moncton, New Brunswick, Canadá, E1C 6Z8
        • The Moncton Hospital
      • Saint John, New Brunswick, Canadá, E2L 4L2
        • Atlantic Health Sciences Corporation-Saint John Regional Hospital
    • Nova Scotia
      • Halifax, Nova Scotia, Canadá, B3H 2Y9
        • QEII Health Sciences Centre/Nova Scotia Health Authority
    • Ontario
      • Hamilton, Ontario, Canadá, L8V 5C2
        • Juravinski Cancer Centre at Hamilton Health Sciences
      • Toronto, Ontario, Canadá, M5G 2M9
        • University Health Network-Princess Margaret Hospital
      • Toronto, Ontario, Canadá, M4N 3M5
        • Odette Cancer Centre- Sunnybrook Health Sciences Centre
    • Quebec
      • Greenfield Park, Quebec, Canadá, J4V 2H1
        • CSSS Champlain-Charles Le Moyne
      • Montreal, Quebec, Canadá, H3H 2R9
        • The Research Institute of the McGill University Health Centre (MUHC)
      • Montreal, Quebec, Canadá, H2W 1S6
        • McGill University Department of Oncology
    • Saskatchewan
      • Regina, Saskatchewan, Canadá, S4T 7T1
        • Allan Blair Cancer Centre
      • Saskatoon, Saskatchewan, Canadá, S7N 4H4
        • Saskatoon Cancer Centre
    • Alabama
      • Birmingham, Alabama, Estados Unidos, 35233
        • University of Alabama at Birmingham Cancer Center
      • Mobile, Alabama, Estados Unidos, 36688
        • University of South Alabama Mitchell Cancer Institute
    • Arizona
      • Scottsdale, Arizona, Estados Unidos, 85259
        • Mayo Clinic in Arizona
      • Tucson, Arizona, Estados Unidos, 85719
        • Banner University Medical Center - Tucson
      • Tucson, Arizona, Estados Unidos, 85719
        • University of Arizona Cancer Center-North Campus
    • Arkansas
      • Little Rock, Arkansas, Estados Unidos, 72205
        • John L McClellan Memorial Veterans Hospital
    • California
      • Antioch, California, Estados Unidos, 94531
        • Kaiser Permanente-Deer Valley Medical Center
      • Duarte, California, Estados Unidos, 91010
        • City of Hope Comprehensive Cancer Center
      • Los Angeles, California, Estados Unidos, 90033
        • USC / Norris Comprehensive Cancer Center
      • Oakland, California, Estados Unidos, 94611
        • Kaiser Permanente-Oakland
      • Palo Alto, California, Estados Unidos, 94304
        • Stanford Cancer Institute Palo Alto
      • Richmond, California, Estados Unidos, 94801
        • Kaiser Permanente-Richmond
      • Sacramento, California, Estados Unidos, 95823
        • Kaiser Permanente-South Sacramento
      • Sacramento, California, Estados Unidos, 95825
        • Kaiser Permanente Sacramento Medical Center
      • San Francisco, California, Estados Unidos, 94115
        • Kaiser Permanente-San Francisco
      • San Jose, California, Estados Unidos, 95119
        • Kaiser Permanente-Santa Teresa-San Jose
      • San Rafael, California, Estados Unidos, 94903
        • Kaiser Permanente-San Rafael
      • Santa Clara, California, Estados Unidos, 95051
        • Kaiser Permanente Medical Center - Santa Clara
      • Santa Rosa, California, Estados Unidos, 95403
        • Kaiser Permanente-Santa Rosa
      • Santa Rosa, California, Estados Unidos, 95403
        • Sutter Pacific Medical Foundation
      • South San Francisco, California, Estados Unidos, 94080
        • Kaiser Permanente-South San Francisco
      • Vallejo, California, Estados Unidos, 94589
        • Kaiser Permanente-Vallejo
      • Walnut Creek, California, Estados Unidos, 94596
        • Kaiser Permanente-Walnut Creek
    • Colorado
      • Aurora, Colorado, Estados Unidos, 80012
        • The Medical Center of Aurora
      • Aurora, Colorado, Estados Unidos, 80045
        • UCHealth University of Colorado Hospital
      • Boulder, Colorado, Estados Unidos, 80303
        • Boulder Community Foothills Hospital
      • Colorado Springs, Colorado, Estados Unidos, 80907
        • Penrose-Saint Francis Healthcare
      • Denver, Colorado, Estados Unidos, 80218
        • Presbyterian - Saint Lukes Medical Center - Health One
      • Denver, Colorado, Estados Unidos, 80220
        • Rose Medical Center
      • Denver, Colorado, Estados Unidos, 80218
        • Rocky Mountain Cancer Centers-Midtown
      • Denver, Colorado, Estados Unidos, 80220
        • Rocky Mountain Cancer Centers-Rose
      • Denver, Colorado, Estados Unidos, 80218
        • Colorado Blood Cancer Institute
      • Denver, Colorado, Estados Unidos, 80222
        • Western States Cancer Research NCORP
      • Denver, Colorado, Estados Unidos, 80218
        • Saint Joseph Hospital - Cancer Centers of Colorado
      • Denver, Colorado, Estados Unidos, 80210
        • AdventHealth Porter
      • Durango, Colorado, Estados Unidos, 81301
        • Mercy Medical Center
      • Englewood, Colorado, Estados Unidos, 80113
        • Mountain Blue Cancer Care Center - Swedish
      • Englewood, Colorado, Estados Unidos, 80113
        • Swedish Medical Center
      • Fort Collins, Colorado, Estados Unidos, 80524
        • Poudre Valley Hospital
      • Golden, Colorado, Estados Unidos, 80401
        • Mountain Blue Cancer Care Center
      • Greeley, Colorado, Estados Unidos, 80631
        • Banner North Colorado Medical Center
      • Greenwood Village, Colorado, Estados Unidos, 80111
        • Rocky Mountain Cancer Centers-Greenwood Village
      • Lakewood, Colorado, Estados Unidos, 80228
        • Rocky Mountain Cancer Centers-Lakewood
      • Lakewood, Colorado, Estados Unidos, 80228
        • CommonSpirit Saint Anthony Hospital Cancer Center
      • Littleton, Colorado, Estados Unidos, 80122
        • AdventHealth Littleton
      • Lone Tree, Colorado, Estados Unidos, 80124
        • Sky Ridge Medical Center
      • Lone Tree, Colorado, Estados Unidos, 80124
        • Rocky Mountain Cancer Centers-Sky Ridge
      • Longmont, Colorado, Estados Unidos, 80501
        • Longmont United Hospital
      • Loveland, Colorado, Estados Unidos, 80539
        • Banner North Colorado Medical Center - Loveland Campus
      • Parker, Colorado, Estados Unidos, 80138
        • Rocky Mountain Cancer Centers-Parker
      • Parker, Colorado, Estados Unidos, 80138
        • AdventHealth Parker
      • Pueblo, Colorado, Estados Unidos, 81004
        • Saint Mary Corwin Medical Center
      • Wheat Ridge, Colorado, Estados Unidos, 80401
        • Intermountain Health Lutheran Hospital
    • Connecticut
      • Farmington, Connecticut, Estados Unidos, 06030
        • University of Connecticut
      • Hartford, Connecticut, Estados Unidos, 06105
        • Smilow Cancer Hospital Care Center at Saint Francis
      • New Britain, Connecticut, Estados Unidos, 06050
        • The Hospital of Central Connecticut
    • Delaware
      • Lewes, Delaware, Estados Unidos, 19958
        • Beebe Medical Center
      • Newark, Delaware, Estados Unidos, 19718
        • Christiana Care Health System-Christiana Hospital
    • District of Columbia
      • Washington D.C., District of Columbia, Estados Unidos, 20016
        • Sibley Memorial Hospital
      • Washington D.C., District of Columbia, Estados Unidos, 20422
        • Veterans Affairs Medical Center -Washington DC
    • Florida
      • Gainesville, Florida, Estados Unidos, 32610
        • UF Health Cancer Institute - Gainesville
      • Jupiter, Florida, Estados Unidos, 33458
        • Jupiter Medical Center
      • Miami Beach, Florida, Estados Unidos, 33140
        • Mount Sinai Medical Center
      • Orlando, Florida, Estados Unidos, 32803
        • AdventHealth Orlando
    • Georgia
      • Augusta, Georgia, Estados Unidos, 30912
        • Augusta University Medical Center
    • Hawaii
      • Honolulu, Hawaii, Estados Unidos, 96813
        • Hawaii Cancer Care Inc - Waterfront Plaza
      • Honolulu, Hawaii, Estados Unidos, 96813
        • Straub Clinic and Hospital
      • Honolulu, Hawaii, Estados Unidos, 96813
        • University of Hawaii Cancer Center
      • Honolulu, Hawaii, Estados Unidos, 96817
        • Queen's Cancer Center - Kuakini
      • Honolulu, Hawaii, Estados Unidos, 96819
        • Kaiser Permanente Moanalua Medical Center
    • Idaho
      • Boise, Idaho, Estados Unidos, 83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Post Falls, Idaho, Estados Unidos, 83854
        • Kootenai Clinic Cancer Services - Post Falls
    • Illinois
      • Bloomington, Illinois, Estados Unidos, 61704
        • Illinois CancerCare-Bloomington
      • Canton, Illinois, Estados Unidos, 61520
        • Illinois CancerCare-Canton
      • Carthage, Illinois, Estados Unidos, 62321
        • Illinois CancerCare-Carthage
      • Chicago, Illinois, Estados Unidos, 60611
        • Northwestern University
      • Chicago, Illinois, Estados Unidos, 60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago, Illinois, Estados Unidos, 60612
        • University of Illinois
      • Chicago, Illinois, Estados Unidos, 60611
        • Hematology and Oncology Associates
      • Decatur, Illinois, Estados Unidos, 62526
        • Decatur Memorial Hospital
      • Decatur, Illinois, Estados Unidos, 62526
        • Heartland Cancer Research NCORP
      • Eureka, Illinois, Estados Unidos, 61530
        • Illinois CancerCare-Eureka
      • Evanston, Illinois, Estados Unidos, 60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Galesburg, Illinois, Estados Unidos, 61401
        • Illinois CancerCare-Galesburg
      • Havana, Illinois, Estados Unidos, 62644
        • Illinois CancerCare-Havana
      • Kewanee, Illinois, Estados Unidos, 61443
        • Illinois CancerCare-Kewanee Clinic
      • Macomb, Illinois, Estados Unidos, 61455
        • Illinois CancerCare-Macomb
      • Maywood, Illinois, Estados Unidos, 60153
        • Loyola University Medical Center
      • Moline, Illinois, Estados Unidos, 61265
        • Trinity Medical Center
      • Monmouth, Illinois, Estados Unidos, 61462
        • Illinois CancerCare-Monmouth
      • Normal, Illinois, Estados Unidos, 61761
        • Illinois CancerCare-Community Cancer Center
      • Ottawa, Illinois, Estados Unidos, 61350
        • Illinois CancerCare-Ottawa Clinic
      • Pekin, Illinois, Estados Unidos, 61554
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, Estados Unidos, 61615
        • Illinois CancerCare-Peoria
      • Peru, Illinois, Estados Unidos, 61354
        • Illinois CancerCare-Peru
      • Princeton, Illinois, Estados Unidos, 61356
        • Illinois CancerCare-Princeton
      • Rockford, Illinois, Estados Unidos, 61104
        • Swedish American Hospital
      • Rockford, Illinois, Estados Unidos, 61114
        • UW Health Carbone Cancer Center Rockford
      • Springfield, Illinois, Estados Unidos, 62781
        • Springfield Memorial Hospital
      • Urbana, Illinois, Estados Unidos, 61801
        • Carle Cancer Center
    • Indiana
      • Merrillville, Indiana, Estados Unidos, 46410
        • Premier Oncology Hematology Associates
    • Iowa
      • Ames, Iowa, Estados Unidos, 50010
        • McFarland Clinic - Ames
      • Iowa City, Iowa, Estados Unidos, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
      • Sioux City, Iowa, Estados Unidos, 51101
        • Siouxland Regional Cancer Center
      • Waterloo, Iowa, Estados Unidos, 50702
        • MercyOne Waterloo Cancer Center
    • Kansas
      • Kansas City, Kansas, Estados Unidos, 66160
        • University of Kansas Cancer Center
      • Prairie Village, Kansas, Estados Unidos, 66208
        • Kansas City NCI Community Oncology Research Program
      • Topeka, Kansas, Estados Unidos, 66606
        • Cotton O'Neil Cancer Center / Stormont Vail Health
    • Kentucky
      • Lexington, Kentucky, Estados Unidos, 40536
        • University of Kentucky/Markey Cancer Center
    • Louisiana
      • Baton Rouge, Louisiana, Estados Unidos, 70809
        • Ochsner Health Center-Summa
      • New Orleans, Louisiana, Estados Unidos, 70121
        • Ochsner Medical Center Jefferson
      • Shreveport, Louisiana, Estados Unidos, 71103
        • LSU Health Sciences Center at Shreveport
    • Maine
      • Bangor, Maine, Estados Unidos, 04401
        • Eastern Maine Medical Center
    • Maryland
      • Baltimore, Maryland, Estados Unidos, 21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
      • Elkton, Maryland, Estados Unidos, 21921
        • Christiana Care - Union Hospital
    • Massachusetts
      • Boston, Massachusetts, Estados Unidos, 02215
        • Dana-Farber Cancer Institute
      • Boston, Massachusetts, Estados Unidos, 02114
        • Massachusetts General Hospital Cancer Center
      • Brighton, Massachusetts, Estados Unidos, 02135
        • Dana-Farber Cancer Institute at Boston Medical Center - Brighton
      • Springfield, Massachusetts, Estados Unidos, 01199
        • Baystate Medical Center
      • Worcester, Massachusetts, Estados Unidos, 01655
        • UMass Memorial Medical Center - University Campus
    • Michigan
      • Ann Arbor, Michigan, Estados Unidos, 48106
        • Michigan Cancer Research Consortium NCORP
      • Ann Arbor, Michigan, Estados Unidos, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Battle Creek, Michigan, Estados Unidos, 49017
        • Bronson Battle Creek
      • Detroit, Michigan, Estados Unidos, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Detroit, Michigan, Estados Unidos, 48236
        • Henry Ford Health Saint John Hospital
      • Escanaba, Michigan, Estados Unidos, 49829
        • OSF Saint Francis Hospital and Medical Group
      • Grand Rapids, Michigan, Estados Unidos, 49503
        • Cancer Research Consortium of West Michigan NCORP
      • Grand Rapids, Michigan, Estados Unidos, 49503
        • Trinity Health Grand Rapids Hospital
      • Grand Rapids, Michigan, Estados Unidos, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Kalamazoo, Michigan, Estados Unidos, 49007
        • West Michigan Cancer Center
      • Muskegon, Michigan, Estados Unidos, 49444
        • Trinity Health Muskegon Hospital
      • Port Huron, Michigan, Estados Unidos, 48060
        • Lake Huron Medical Center
      • Reed City, Michigan, Estados Unidos, 49677
        • Corewell Health Reed City Hospital
      • Traverse City, Michigan, Estados Unidos, 49684
        • Munson Medical Center
      • Warren, Michigan, Estados Unidos, 48093
        • Henry Ford Health Warren Hospital
    • Minnesota
      • Bemidji, Minnesota, Estados Unidos, 56601
        • Sanford Joe Lueken Cancer Center
      • Burnsville, Minnesota, Estados Unidos, 55337
        • Fairview Ridges Hospital
      • Coon Rapids, Minnesota, Estados Unidos, 55433
        • Mercy Hospital
      • Duluth, Minnesota, Estados Unidos, 55805
        • Essentia Health Cancer Center
      • Edina, Minnesota, Estados Unidos, 55435
        • Fairview Southdale Hospital
      • Fridley, Minnesota, Estados Unidos, 55432
        • Unity Hospital
      • Hutchinson, Minnesota, Estados Unidos, 55350
        • Hutchinson Area Health Care
      • Maplewood, Minnesota, Estados Unidos, 55109
        • Saint John's Hospital - Healtheast
      • Maplewood, Minnesota, Estados Unidos, 55109
        • Minnesota Oncology Hematology PA-Maplewood
      • Minneapolis, Minnesota, Estados Unidos, 55415
        • Hennepin County Medical Center
      • Minneapolis, Minnesota, Estados Unidos, 55407
        • Abbott-Northwestern Hospital
      • Minneapolis, Minnesota, Estados Unidos, 55417
        • Minneapolis VA Medical Center
      • Robbinsdale, Minnesota, Estados Unidos, 55422
        • North Memorial Medical Health Center
      • Rochester, Minnesota, Estados Unidos, 55905
        • Mayo Clinic in Rochester
      • Saint Cloud, Minnesota, Estados Unidos, 56303
        • Coborn Cancer Center at Saint Cloud Hospital
      • Saint Louis Park, Minnesota, Estados Unidos, 55416
        • Park Nicollet Clinic - Saint Louis Park
      • Saint Louis Park, Minnesota, Estados Unidos, 55416
        • Metro Minnesota Community Oncology Research Consortium
      • Saint Paul, Minnesota, Estados Unidos, 55101
        • Regions Hospital
      • Saint Paul, Minnesota, Estados Unidos, 55102
        • United Hospital
      • Shakopee, Minnesota, Estados Unidos, 55379
        • Saint Francis Regional Medical Center
      • Stillwater, Minnesota, Estados Unidos, 55082
        • Lakeview Hospital
      • Waconia, Minnesota, Estados Unidos, 55387
        • Ridgeview Medical Center
      • Willmar, Minnesota, Estados Unidos, 56201
        • Rice Memorial Hospital
      • Woodbury, Minnesota, Estados Unidos, 55125
        • Minnesota Oncology Hematology PA-Woodbury
    • Mississippi
      • Jackson, Mississippi, Estados Unidos, 39216
        • University of Mississippi Medical Center
    • Missouri
      • Cape Girardeau, Missouri, Estados Unidos, 63703
        • Saint Francis Medical Center
      • Columbia, Missouri, Estados Unidos, 65201
        • Veterans Administration
      • Columbia, Missouri, Estados Unidos, 65212
        • MU Health - University Hospital/Ellis Fischel Cancer Center
      • Kansas City, Missouri, Estados Unidos, 64111
        • Saint Luke's Hospital of Kansas City
      • St Louis, Missouri, Estados Unidos, 63141
        • Mercy Hospital Saint Louis
      • St Louis, Missouri, Estados Unidos, 63141
        • Saint Louis-Cape Girardeau CCOP
    • Montana
      • Billings, Montana, Estados Unidos, 59101
        • Billings Clinic Cancer Center
      • Bozeman, Montana, Estados Unidos, 59715
        • Bozeman Health Deaconess Hospital
    • New Jersey
      • Camden, New Jersey, Estados Unidos, 08103
        • Cooper Hospital University Medical Center
    • New Mexico
      • Albuquerque, New Mexico, Estados Unidos, 87106
        • University of New Mexico Cancer Center
      • Albuquerque, New Mexico, Estados Unidos, 87110
        • Presbyterian Kaseman Hospital
    • New York
      • Buffalo, New York, Estados Unidos, 14263
        • Roswell Park Cancer Institute
      • Lake Success, New York, Estados Unidos, 11042
        • Northwell Health/Center for Advanced Medicine
      • Manhasset, New York, Estados Unidos, 11030
        • North Shore University Hospital
      • Mineola, New York, Estados Unidos, 11501
        • NYU Langone Hospital - Long Island
      • New York, New York, Estados Unidos, 10065
        • NYP/Weill Cornell Medical Center
      • Rochester, New York, Estados Unidos, 14642
        • University of Rochester
      • The Bronx, New York, Estados Unidos, 10467
        • Montefiore Medical Center - Moses Campus
      • The Bronx, New York, Estados Unidos, 10461
        • Montefiore Medical Center-Weiler Hospital
    • North Carolina
      • Asheboro, North Carolina, Estados Unidos, 27203
        • Randolph Hospital
      • Goldsboro, North Carolina, Estados Unidos, 27534
        • Wayne Memorial Hospital
      • Greensboro, North Carolina, Estados Unidos, 27403
        • Cone Health Cancer Center
      • Hendersonville, North Carolina, Estados Unidos, 28791
        • Margaret R Pardee Memorial Hospital
      • Kinston, North Carolina, Estados Unidos, 28501
        • ECU Health Oncology Kinston
      • Pinehurst, North Carolina, Estados Unidos, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Reidsville, North Carolina, Estados Unidos, 27320
        • Annie Penn Memorial Hospital
      • Statesville, North Carolina, Estados Unidos, 28677
        • Iredell Memorial Hospital
      • Winston-Salem, North Carolina, Estados Unidos, 27104
        • Southeast Clinical Oncology Research Consortium NCORP
    • North Dakota
      • Bismarck, North Dakota, Estados Unidos, 58501
        • Sanford Bismarck Medical Center
      • Bismarck, North Dakota, Estados Unidos, 58501
        • Mid Dakota Clinic
      • Fargo, North Dakota, Estados Unidos, 58122
        • Sanford Roger Maris Cancer Center
      • Fargo, North Dakota, Estados Unidos, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Beachwood, Ohio, Estados Unidos, 44122
        • Cleveland Clinic Cancer Center Beachwood
      • Cincinnati, Ohio, Estados Unidos, 45219
        • University of Cincinnati Cancer Center-UC Medical Center
      • Cleveland, Ohio, Estados Unidos, 44106
        • Case Western Reserve University
      • Cleveland, Ohio, Estados Unidos, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Estados Unidos, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, Estados Unidos, 43214
        • Riverside Methodist Hospital
      • Columbus, Ohio, Estados Unidos, 43219
        • The Mark H Zangmeister Center
      • Columbus, Ohio, Estados Unidos, 43222
        • Mount Carmel Health Center West
      • Columbus, Ohio, Estados Unidos, 43215
        • Columbus NCI Community Oncology Research Program
      • Dayton, Ohio, Estados Unidos, 45409
        • Miami Valley Hospital
      • Independence, Ohio, Estados Unidos, 44131
        • Cleveland Clinic Cancer Center Independence
      • Marietta, Ohio, Estados Unidos, 45750
        • Marietta Memorial Hospital
      • Mayfield Heights, Ohio, Estados Unidos, 44124
        • Hillcrest Hospital Cancer Center
      • Newark, Ohio, Estados Unidos, 43055
        • Licking Memorial Hospital
      • Parma, Ohio, Estados Unidos, 44129
        • University Hospitals Parma Medical Center
      • Sandusky, Ohio, Estados Unidos, 44870
        • North Coast Cancer Care
      • Springfield, Ohio, Estados Unidos, 45504
        • Springfield Regional Medical Center
      • Strongsville, Ohio, Estados Unidos, 44136
        • Cleveland Clinic Cancer Center Strongsville
      • Sylvania, Ohio, Estados Unidos, 43560
        • ProMedica Flower Hospital
      • Toledo, Ohio, Estados Unidos, 43614
        • University of Toledo
      • Westerville, Ohio, Estados Unidos, 43081
        • Saint Ann's Hospital
      • Wooster, Ohio, Estados Unidos, 44691
        • Cleveland Clinic Wooster Family Health and Surgery Center
    • Oklahoma
      • Norman, Oklahoma, Estados Unidos, 73071
        • Cancer Care Associates-Norman
      • Oklahoma City, Oklahoma, Estados Unidos, 73104
        • University of Oklahoma Health Sciences Center
      • Oklahoma City, Oklahoma, Estados Unidos, 73120
        • Mercy Hospital Oklahoma City
    • Oregon
      • Gresham, Oregon, Estados Unidos, 97030
        • Legacy Mount Hood Medical Center
      • Milwaukie, Oregon, Estados Unidos, 97222
        • Providence Milwaukie Hospital
      • Newberg, Oregon, Estados Unidos, 97132
        • Providence Newberg Medical Center
      • Oregon City, Oregon, Estados Unidos, 97045
        • Providence Willamette Falls Medical Center
      • Portland, Oregon, Estados Unidos, 97210
        • Legacy Good Samaritan Hospital and Medical Center
      • Portland, Oregon, Estados Unidos, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, Estados Unidos, 97225
        • Providence Saint Vincent Medical Center
    • Pennsylvania
      • Allentown, Pennsylvania, Estados Unidos, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Carlisle, Pennsylvania, Estados Unidos, 17015
        • Carlisle Regional Cancer Center
      • Danville, Pennsylvania, Estados Unidos, 17822
        • Geisinger Medical Center
      • Doylestown, Pennsylvania, Estados Unidos, 18901
        • Doylestown Hospital
      • Hazleton, Pennsylvania, Estados Unidos, 18201
        • Geisinger Medical Center-Cancer Center Hazleton
      • Hershey, Pennsylvania, Estados Unidos, 17033-0850
        • Penn State Milton S Hershey Medical Center
      • Pittsburgh, Pennsylvania, Estados Unidos, 15232
        • UPMC Hillman Cancer Center
      • Sayre, Pennsylvania, Estados Unidos, 18840
        • Guthrie Medical Group PC-Robert Packer Hospital
      • West Reading, Pennsylvania, Estados Unidos, 19611
        • Reading Hospital
      • Wilkes-Barre, Pennsylvania, Estados Unidos, 18711
        • Geisinger Wyoming Valley/Henry Cancer Center
    • South Carolina
      • Boiling Springs, South Carolina, Estados Unidos, 29316
        • Prisma Health Cancer Institute - Spartanburg
      • Charleston, South Carolina, Estados Unidos, 29401
        • Roper Hospital
      • Greenville, South Carolina, Estados Unidos, 29605
        • Prisma Health Cancer Institute - Faris
      • Greenville, South Carolina, Estados Unidos, 29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville, South Carolina, Estados Unidos, 29605
        • Prisma Health Cancer Institute - Butternut
      • Greenville, South Carolina, Estados Unidos, 29601
        • Saint Francis Hospital
      • Greenville, South Carolina, Estados Unidos, 29605
        • Prisma Health Greenville Memorial Hospital
      • Seneca, South Carolina, Estados Unidos, 29672
        • Prisma Health Cancer Institute - Seneca
      • Spartanburg, South Carolina, Estados Unidos, 29303
        • Spartanburg Medical Center
    • South Dakota
      • Rapid City, South Dakota, Estados Unidos, 57701
        • Rapid City Regional Hospital
      • Sioux Falls, South Dakota, Estados Unidos, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
      • Sioux Falls, South Dakota, Estados Unidos, 57104
        • Sanford Cancer Center Oncology Clinic
    • Tennessee
      • Knoxville, Tennessee, Estados Unidos, 37916
        • Covenant Health Cancer Centers
      • Nashville, Tennessee, Estados Unidos, 37232
        • Vanderbilt University/Ingram Cancer Center
    • Texas
      • Amarillo, Texas, Estados Unidos, 79106
        • The Don and Sybil Harrington Cancer Center
      • Dallas, Texas, Estados Unidos, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
    • Utah
      • Salt Lake City, Utah, Estados Unidos, 84112
        • Huntsman Cancer Institute/University of Utah
    • Virginia
      • Martinsville, Virginia, Estados Unidos, 24112
        • Sovah Health Martinsville
    • Washington
      • Vancouver, Washington, Estados Unidos, 98664
        • PeaceHealth Southwest Medical Center
    • West Virginia
      • Morgantown, West Virginia, Estados Unidos, 26506
        • West Virginia University Healthcare
    • Wisconsin
      • Chippewa Falls, Wisconsin, Estados Unidos, 54729
        • Marshfield Clinic-Chippewa Center
      • Eau Claire, Wisconsin, Estados Unidos, 54701
        • HSHS Sacred Heart Hospital
      • Eau Claire, Wisconsin, Estados Unidos, 54701
        • Marshfield Clinic Cancer Center at Sacred Heart
      • Green Bay, Wisconsin, Estados Unidos, 54311
        • Aurora BayCare Medical Center
      • Green Bay, Wisconsin, Estados Unidos, 54301
        • Saint Vincent Hospital Cancer Center Green Bay
      • Green Bay, Wisconsin, Estados Unidos, 54303
        • Saint Vincent Hospital Cancer Center at Saint Mary's
      • Green Bay, Wisconsin, Estados Unidos, 54301-3526
        • Green Bay Oncology at Saint Vincent Hospital
      • Janesville, Wisconsin, Estados Unidos, 53548
        • Mercyhealth Hospital and Cancer Center - Janesville
      • La Crosse, Wisconsin, Estados Unidos, 54601
        • Gundersen Lutheran Medical Center
      • Madison, Wisconsin, Estados Unidos, 53715
        • SSM Health Dean Medical Group - South Madison Campus
      • Marinette, Wisconsin, Estados Unidos, 54143
        • Aurora Bay Area Medical Group-Marinette
      • Marinette, Wisconsin, Estados Unidos, 54143
        • Bay Area Medical Center
      • Marshfield, Wisconsin, Estados Unidos, 54449
        • Marshfield Medical Center-Marshfield
      • Marshfield, Wisconsin, Estados Unidos, 54449
        • Marshfield Medical Center
      • Milwaukee, Wisconsin, Estados Unidos, 53226
        • Medical College of Wisconsin
      • Minocqua, Wisconsin, Estados Unidos, 54548
        • Marshfield Medical Center - Minocqua
      • Oconomowoc, Wisconsin, Estados Unidos, 53066
        • ProHealth Oconomowoc Memorial Hospital
      • Oconto Falls, Wisconsin, Estados Unidos, 54154
        • Saint Vincent Hospital Cancer Center at Oconto Falls
      • Rhinelander, Wisconsin, Estados Unidos, 54501
        • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
      • Rice Lake, Wisconsin, Estados Unidos, 54868
        • Marshfield Medical Center-Rice Lake
      • Stevens Point, Wisconsin, Estados Unidos, 54481
        • Aspirus Cancer Care - Stevens Point
      • Summit, Wisconsin, Estados Unidos, 53066
        • Aurora Medical Center in Summit
      • Waukesha, Wisconsin, Estados Unidos, 53188
        • ProHealth Waukesha Memorial Hospital
      • Wauwatosa, Wisconsin, Estados Unidos, 53226
        • Aurora Cancer Care-Milwaukee West
      • Weston, Wisconsin, Estados Unidos, 54476
        • Marshfield Medical Center - Weston
      • Wisconsin Rapids, Wisconsin, Estados Unidos, 54494
        • Marshfield Clinic - Wisconsin Rapids Center

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Patients must have morphologically confirmed diagnosis of myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) based on one of the following:

    • French-American-British (FAB) classifications:

      • Refractory anemia with excess blasts (RAEB - defined as having 5-20% myeloblasts in the bone marrow)
      • Chronic myelomonocytic leukemia (CMML) with 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood
    • World Health Organization (WHO) classifications:

      • Refractory anemia with excess blasts-1 (RAEB-1 - defined as having 5-9% myeloblasts in the bone marrow)
      • Refractory anemia with excess blasts-2 (RAEB-2 - defined as having 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood)
      • Chronic myelomonocytic leukemia-1 (CMML-1 - defined as having < 10% myeloblasts in the bone marrow and/or < 5% blasts in the blood)
      • Chronic myelomonocytic leukemia-2 (CMML-2 - defined as having 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood) OR
    • International prognostic score (IPSS) of intermediate 2 (1.5-2.0 points) or high (>= 2.5 points); a score of intermediate 1 (0.5-1.0 points) is only allowable in the setting of >= 5% myeloblasts

    • NOTE: Patients with acute myeloid leukemia (AML) are not eligible

    • Procedures to obtain specimens for establishing baseline disease must be done within 30 days prior to registration

  • Patients must not have received lenalidomide, azacitidine, vorinostat, or decitabine as treatment previously; any hematopoietic growth factors must be stopped for at least 14 days prior to registration; patients may have received low-dose cytarabine for MDS treatment previously, but they must have discontinued its use for at least 28 days prior to registration; patients may have received prior hydroxyurea per CMML treatment previously, but they must have discontinued its use for at least 7 days prior to registration; these patients will not be eligible if white blood cell (WBC) > 30,000/mm^3

  • Patients must not have received radiation therapy, chemotherapy, or cytotoxic therapy to treat conditions other than MDS within 12 months prior to registration

  • Patients must not have undergone prior allogeneic stem cell or bone marrow transplantation at any time; patients that have undergone an autologous stem cell transplant are eligible

  • Patients must not have used or be using histone deacetylase (HDAC) inhibitor agents for anticancer treatment

  • Patients may not have received agents such as valproic acid for epilepsy within 30 days prior to registration

  • Patients must have Zubrod performance status of 0-2

  • Patients must not have any pre-existing neurotoxicity/neuropathy of >= grade 2 according to the National Cancer Institute (NCI) Common Toxicity Criteria version 4.0, or prior >= grade 3 allergic reaction/hypersensitivity or rash to thalidomide, that has not resolved to < grade 2

  • Patients must not have any serious medical condition, laboratory abnormality, or psychiatric illness that, in the view of the treating physician, would place the participant at an unacceptable risk if he or she were to participate in the study or would prevent that person from giving informed consent

  • Patients must not have history of thromboembolic event or other condition requiring current use of anticoagulation with Coumadin (warfarin) or low molecular-weight heparin

  • Patients must not have known or suspected hypersensitivity to mannitol

  • Patients must receive a 12-lead electrocardiogram (EKG), chest x-ray or computed tomography (CT) scan, serum creatinine, complete metabolic panel including serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT), electrolytes, and bilirubin testing within 28 days prior to registration in order to establish baseline measurements; questions regarding patient safety in regards to results of these tests should be directed to the study chair

  • Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL within 10 - 14 days prior to registration; FCBP must agree to have a second pregnancy test within 24 hours prior to starting cycle 1 if randomized to receive lenalidomide

    • Further, patients commit to the following if they are randomized to receive lenalidomide: FCBP must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control: one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before starting lenalidomide; FCBP must also agree to ongoing pregnancy testing; men must agree to use a latex condom during sexual contact with a FCBP, even if they have had a successful vasectomy; a FCBP is a sexually mature woman who: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months); all patients must be counseled by a trained counselor every 28 days about pregnancy precautions and risks of fetal exposure
    • NOTE: Patients not randomized to receive lenalidomide will not be required to undergo serial pregnancy testing or lenalidomide counseling after registration
  • No prior malignancy is allowed except for adequately treated basal cell (or squamous cell) skin cancer, in situ cervical cancer, or other cancer for which the patient has been disease-free for three years

  • Cytogenetics requirements:

    • Southwestern Oncology Group (SWOG) (and other sites not affiliated with Alliance or Eastern Cooperative Oncology Group [ECOG]-American College of Radiology Imaging Network [ACRIN]): Pretreatment cytogenetics must be performed on all patients; collection of pretreatment specimens must be completed within 30 days prior to registration to S1117; specimens must be submitted to the site's preferred Clinical Laboratory Improvement Amendments (CLIA)-approved cytogenetics laboratory; reports of the results must be submitted as described; note that cytogenetics are required at other timepoints; NOTE: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) sites may submit specimens to College of American Pathologists (CAP) or Ontario Laboratory Accreditation (OLA)-approved laboratories providing the lab is licensed to perform fluorescent in situ hybridization (FISH) analysis
    • Alliance: Alliance patients must enroll on Cancer and Leukemia Group B (CALGB) 8461, the cytogenetics protocol; CALGB 8461 provides sample procurement and submission instructions to Alliance-approved institutional cytogeneticists; note that cytogenetics are required at other timepoints
    • ECOG-ACRIN: Pretreatment cytogenetics must be performed on all patients; collection of pretreatment specimens must be completed within 30 days prior to registration to S1117; specimens must be submitted to the site's preferred CLIA-approved cytogenetics laboratory; karyotypes and reports must be submitted for review to the Mayo Clinic Cytogenetics Laboratory in Rochester; note that cytogenetics testing is required at other timepoints
  • Banking requirements:

    • SWOG, Alliance and ECOG-ACRIN (and other sites not affiliated with NCIC CTG): Patients must be offered participation in specimen banking; with patient consent, specimens must be submitted as outlined
    • Alliance: (Temporarily Closed 2/28/14): As of February 28, 2014, CALGB 9665 has been temporarily closed, so Alliance patients under consideration for S1117 are NOT to be registered to CALGB 9665 and no specimens for patients enrolled after February 28, 2014 are to be submitted via this ancillary study; these patients should submit specimens per SWOG instructions; patients already enrolled on CALGB 9665 should continue to submit specimens per instructions in CALGB 9665
    • NCIC CTG: NCIC CTG patients must be offered participation in specimen submission and banking; with patient consent, specimens must be submitted as outlined
  • All patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

  • As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Arm I (azacitidine and lenalidomide)

Patients receive azacitidine SC or IV on days 1-7 or days 1-5 and 8-9, and lenalidomide PO QD on days 1-21. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

Correlative studies

Given PO

Otros nombres:
  • CC-5013
  • Revlimid
  • CC5013
  • CDC 501
  • CC 5013

Given SC or IV

Otros nombres:
  • 5 azc
  • 5-CA
  • 5-azacitidina
  • 5-AZC
  • Azacitidina
  • Azacitidina, 5-
  • Ladakamicina
  • Milosar
  • U-18496
  • Vidaza
Experimental: Arm II (azacitidine)

Patients receive azacitidine as in Arm I. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

Correlative studies

Given SC or IV

Otros nombres:
  • 5 azc
  • 5-CA
  • 5-azacitidina
  • 5-AZC
  • Azacitidina
  • Azacitidina, 5-
  • Ladakamicina
  • Milosar
  • U-18496
  • Vidaza
Experimental: Arm III (azacitidine and vorinostat)

Patients receive azacitidine as in Arm I and vorinostat PO BID on days 3-9. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

Correlative studies

Given SC or IV

Otros nombres:
  • 5 azc
  • 5-CA
  • 5-azacitidina
  • 5-AZC
  • Azacitidina
  • Azacitidina, 5-
  • Ladakamicina
  • Milosar
  • U-18496
  • Vidaza

Given PO

Otros nombres:
  • SAHA
  • Ácido hidroxámico de suberoilanilida
  • MSK-390
  • Zolinza
  • L-001079038
  • Ácido suberanilohidroxámico

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Response Rate (Phase II)
Periodo de tiempo: Up to 5 years

A response is any of complete hematological remission, partial remission, or hematologic improvement.

Up to 5 years
Overall Survival (Phase III)
Periodo de tiempo: Up to 5 years

OS is calculated for all patients from the date of initial registration to date of death due to any cause. The follow-up for patients last known to be alive is censored at the date of last contact. Stratified Cox regression models will be used to compare OS of the combination arm selected in the Phase II portion of the trial to OS of the single-agent azacitidine arm.

Up to 5 years

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Relapse-free Survival
Periodo de tiempo: Up to 5 years

RFS is calculated for patients who have achieved a response. RFS will be measured from the date of response to the date of first documentation of relapse from response (as defined in the primary objective), or death due to any cause. The follow-up for patients last known to be alive and without report of relapse is censored at the date of last contact. RFS will be estimated for each of the three arms using the Kaplan-Meier method.

Up to 5 years
Overall Survival
Periodo de tiempo: Up to 5 years

OS is calculated for all patients from the date of initial registration to date of death due to any cause. The follow- up for patients last known to be alive is censored at the date of last contact. OS will be estimated for each of the three arms using the Kaplan-Meier method.

Up to 5 years
Pre-study Cytogenetic Abnormalities
Periodo de tiempo: Up to 5 years

Cytogenetic risk group is used to identify cytogenetic abnormalities.

Up to 5 years
Toxicity Rate
Periodo de tiempo: Up to 5 years

Adverse events that are possibly, probably or definitely related to study drug are reported.

Up to 5 years

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Mikkael A Sekeres, SWOG Cancer Research Network

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de marzo de 2012

Finalización primaria (Actual)

1 de junio de 2015

Finalización del estudio (Estimado)

31 de marzo de 2027

Fechas de registro del estudio

Enviado por primera vez

27 de enero de 2012

Primero enviado que cumplió con los criterios de control de calidad

27 de enero de 2012

Publicado por primera vez (Estimado)

1 de febrero de 2012

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

13 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de noviembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • NCI-2012-00242
  • U10CA032102 (Subvención/contrato del NIH de EE. UU.)
  • U10CA180888 (Subvención/contrato del NIH de EE. UU.)
  • NCI-2012-00242 (Identificador de registro: CTRP (Clinical Trial Reporting Program))
  • CDR0000723909
  • SWOG-S1117
  • S1117 (Otro identificador: CTEP)
  • S1117 (Otro identificador: SWOG)

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir